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Abstract
Background: Safe drinking water is critical for health. Household water treatment (HWT) has been recommended for
improving access to potable water where existing sources are unsafe. Reports of low adherence to HWT may limit the
usefulness of this approach, however.
Methods and Findings: We constructed a quantitative microbial risk model to predict gains in health attributable to water
quality interventions based on a range of assumptions about pre-treatment water quality; treatment effectiveness in
reducing bacteria, viruses, and protozoan parasites; adherence to treatment interventions; volume of water consumed per
person per day; and other variables. According to mean estimates, greater than 500 DALYs may be averted per 100,000
person-years with increased access to safe water, assuming moderately poor pre-treatment water quality that is a source of
risk and high treatment adherence (.90% of water consumed is treated). A decline in adherence from 100% to 90% reduces
predicted health gains by up to 96%, with sharpest declines when pre-treatment water quality is of higher risk.
Conclusions: Results suggest that high adherence is essential in order to realize potential health gains from HWT.
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Introduction
Over 780 million people now lack access to an ‘‘improved’’
water source [1], and one study has estimated the number of
people who rely on microbiologically or chemically unsafe water to
be 1.8 billion, or about 28% of the global population [2]. Unsafe
drinking water is a leading cause of preventable disease, with the
burden borne primarily by children in low and middle-income
countries. Pathogens transmitted in drinking water account for an
unknown but presumed significant percentage of the estimated 4
billion cases and 1.9 million deaths from diarrhoeal diseases each
year [3,4]. According to WHO and UNICEF monitoring data
from 2004, diarrhoeal diseases are the second most common cause
of deaths among children under 5 years of age worldwide, or 16%
of the total [5].
Providing safe, reliable, piped-in water to every household is an
essential goal, yielding optimal health gains while contributing to
the Millennium Development Goal targets for poverty reduction,
nutrition, childhood survival, school attendance, gender equity
and environmental sustainability. Recent research has shown,
however, that even such improved water supplies are often subject
to faecal contamination [2] and that even occasional interruptions
in the quality of water from piped water supplies can undermine
the health benefits from safe drinking water [6]. While careful not
to encourage diversion of resources away from expansion of safe
piped water, public health officials have called for alternative
approaches that may provide some of the health benefits of safe
drinking-water as progress is made in improving infrastructure
services [7].
One such alternative is household water treatment and safe
storage (HWT) [8]. In many settings, both rural and urban,
populations may have access to sufficient quantities of water, but
that water may be unsafe for consumption as a result of microbial
or chemical contamination. Effective HWT, such as boiling,
filtration and chlorination, has been shown significantly improve
microbial water quality [9,10,11,12]. Moreover, by focusing on
the point of use rather than the point of delivery, treating water at
the household level minimizes the risk of recontamination [13] and
the risk of contamination associated with poorly functioning or
intermittent water supply systems. There is evidence that HWT
can be effective in preventing self-reported diarrhoeal disease
[14,15,16,17], although systematic reviews have noted that the
limited number of placebo-controlled trials have not reported a
statistically significant reduction in risk and estimates of effect from
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[15,18]. Like other environmental health interventions such as
sanitation or hygiene, blinding intervention studies of HWT has
proved to be challenging, but additional blinded trials may be
useful in evaluating the evidence for this strategy of safe water
provision.
One of the other challenges that promoters of HWT have
reported is lack of adherence—correct, consistent and sustained use,
sometimes referred to as compliance. Unlike centrally treated, piped-
in water supplies, HWT is normally a batch process that must be
undertaken by the end users on a daily or other frequent basis in
order to provide consistent protection against waterborne patho-
gens. A systematic review of chlorine-based HWT, where
adherence can be objectively assessed by residual free chlorine
in treated water, found several studies with adherence under 70%
[14]. Even when uptake of an HWT filter intervention was high
when measured by current use, 83% of adults and 95% of children
were reported to also consume untreated water [19]. A number of
other studies of HWT reported reduced use of interventions over
time, raising questions about whether low adherence may limit the
usefulness of HWT as a strategy for securing access to safe water
[19,20,21,22,23,24].
To date, however, there is limited evidence characterizing the
impact of adherence on health gains attributable to HWT. A
systematic review of water quality interventions to prevent
diarrhoea reported a pooled risk ratio of 0.46 (95% CI: 0.25–
0.84) among 16 trials reporting adherence over 50%, and 0.75
(95% CI: 0.63–0.90) among 5 trials reporting adherence of less
than 50% [14]. In a review of chlorine interventions, Arnold and
Colford (2007) found that the reduction of diarrhoeal disease was
greater in studies that reported a higher percentage of samples
with detectable levels of chlorine at the point of use [14]. Despite
the limited evidence from reviews, the relationship between
adherence and health impact has not been clearly characterised in
field trials [16]. This is partly due to the difficulty of measuring
adherence in a field setting for many technologies, especially at the
level of the individual. Adherence has not been measured or
reported in the majority of field trials of HWT to date.
In this paper, we present a basic quantitative microbial risk
model examining the influence of pre-treatment water quality,
treatment effectiveness, and adherence on predicted health gains.
We seek to estimate the magnitude of the effect of variable
adherence on health impacts achievable through safe water
interventions, particularly HWT.
Methods
We constructed a quantitative microbial risk assessment
(QMRA) model using assumptions for ranges of untreated and
treated water quality, published dose-response relationships for
reference pathogens, per-case severity weighting, population
susceptibility, adherence, and per-capita consumption of drinking
water. In most cases, we used the default assumptions and methods
articulated in and recommended by the World Health Organiza-
tion (WHO)’s Guidelines for Drinking-water Quality (GDWQ),4
th
Edition [25], where the rationale, caveats, and methodological
issues that apply to this approach to estimating health risks are
described in greater detail. We briefly describe the method here
and provide a summary of calculations.
We report model output in disability-adjusted life years
(DALYs) averted per 100,000 people per year attributable to
HWT under the conditions we describe. DALYs can be used to
compare health outcomes using severity and duration estimates of
disease(s), combining quality and quantity of life factors [25,26].
This measure has been extensively described previously [27] and is
used here for ease of comparison with other health impact
estimates.
Reference pathogens
We used Campylobacter jejuni, rotavirus, and Cryptosporidium as
reference pathogens in this risk assessment because of their
relatively low infectious doses, high per-case DALY severity
weighting, and the fact that we have published dose-response
models for them [25]. The DALY estimates we calculated were
intended to estimate the DALY contributions from bacteria,
viruses, and protozoa (as classes of pathogens) that may be found
in untreated water, following the approach of the WHO
recommended model [25]. It is important to note that the use of
these specific microbes is not a statement about their relative
importance as aetiologic agents of diarrhoeal diseases globally, or
their importance as specifically waterborne pathogens. Rotavirus,
for example, is thought to be more frequently transmitted via
pathways other than drinking water. They are all known and
relatively common causes of gastrointestinal illness. We list
assumptions for pathogen-specific per-case DALY weighting,
population susceptibility, and risk of illness following infection in
Table 1 and present an overview of dose-response calculations
below.
Water quality assumptions
The use of QMRA models to predict reductions in waterborne
disease risk requires estimation of pre- and post-treatment
concentrations of microbes for which we have dose-response
models. Faecal-oral pathogen occurrence and distribution are
variable in drinking water sources and depend on many factors,
including infection (and shedding) rates of specific pathogens in a
given population, sanitation and hygiene conditions that may
affect excreta containment, zoonotic reservoirs, seasonality and
weather events, and other context-specific variables. No sufficient-
ly detailed, country-level or international data exist for waterborne
pathogens that would permit the meaningful estimation of means
to be used in a generalizable and scientifically credible risk
assessment model for drinking water risk. We have used
assumptions for microbial counts in pre-treatment waters over a
range from 0.0001 per litre (‘‘low risk’’) to 1 per litre (‘‘high risk’’).
For the purposes of this modelling exercise, we have assigned a
log-normal probability density function to water quality assump-
tions, which is one distribution that has been observed to
characterize microbial density in water [28,29].
Treatment effectiveness
We modelled DALYs averted for improved drinking water
quality under several different assumptions about microbiological
effectiveness, including: (1), a hypothetical ‘‘best case’’ technology
that would be able to reduce bacteria, viruses, and protozoa by
3.01–6 log10 (99.9%–99.9999%), typical of the most advanced
single or multiple-barrier technologies for household water
treatment [30,31,32] and consistent with well operated conven-
tional or advanced water treatment; (2), a mid-range treatment
option that could reduce all classes of microbes by 2.01–3 log10
(99%–99.9%), in the range of basic drinking water treatment and
consistent with effective HWT options; and (3), a basic level of
protection corresponding to poorly performing water treatment
systems, systems without adequate disinfection, or some single-
barrier HWT options (1–2 log10 reduction, or 90%–99%) [25]. In
the probabilistic model, we assumed a uniform probability density
function between the upper and lower log10 bounds we specify.
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For safer water to translate into health gains, the percentage of
treated water that is consumed is an important factor. For piped-
in, domestic water service, this might be called consistency of
treatment. In household water treatment, this may be called adherence
and sometimes compliance. For the purposes of this modelling
exercise, we use adherence and define it as the percentage of water
an individual uses that is treated (0%–100%). We have divided
adherence into high (91%–100%), medium (71%–90%), and low
(50%–70%), with an assumed uniform probability density function
describing the likelihood of values within this range in the
probabilistic model. We assume here that the balance of the
drinking water consumed by the user is untreated water. In reality,
individuals and families may rely on a number of drinking water
sources and treatment options, and these options may be a
function of location, season, preferences, beliefs, knowledge,
convenience, infrastructure, cost, previous household investment
(e.g., a well or rainwater storage), or other factors. Our simplified
assumption is that users have two options: treated water and
untreated water that result in microbial risks that vary according to
the assumptions we have specified.
Model structure
We used Oracle Crystal Ball, Fusion Edition (release
11.1.2.1.000, www.oracle.com) to build a stochastic (Monte Carlo)
model based on probability density functions (pdfs) specified for
key high-leverage variables of interest, while conserving point
estimates for other variables in the base model [25] and using a
single-hit version for sensitivity analysis. Model output was
collected following 10,000 simulations of each model configuration
and descriptive statistics were computed in Crystal Ball. Model
predictive and structural validity were tested using both the single-
hit and probabilistic models using a structured comparison of
model output across a range of default assumptions.
Table 1 describes the basic model structure. Pre-treatment
water quality is assumed with means of 0.0001–1 per litre,
distributed log-normally (CR). Based on effectiveness of treatment
in reducing reference pathogens, treated drinking-water quality is
calculated (CR). We then used assumed consumption of water per
day (V) and adherence or consistency of water treatment (A) to
calculate the predicted exposure by drinking-water (d) as the
number of microbes ingested per day.
d~CDVAzCR 1{A ðÞ ð 1Þ
We used the exponential (Cryptosporidium) and the Beta-Poisson
(rotavirus, Campylobacter) models to estimate the risk of infection
from exposure to microbial pathogens [26]. We calculated the risk
of infection of a single microbe (d) and then calculated the annual
risk from ingestion of multiple microbes over the period of a year.
The exponential model is:
Pinf d ðÞ ~1{e{rd ð2Þ
Where P(d) is the probability of an individual becoming infected
after ingesting a dose (d) and r is an infectivity constant. The value
of r is 0.2 for Cryptosporidium (Table 1) [25].
The equation for the Beta-Poisson model is:
Pinf d ðÞ ~1{ 1z
d
N50
2
1
!{1
  {!
ð3Þ
N50 is the median infective dose, which has been experimentally
derived as the dose estimated to cause infection in 50% of
individuals exposed, and a is a dimensionless infectivity constant.
The values for N50 and a are 896 and 0.145 for Campylobacter,
respectively, and 6.17 and 0.253 for rotavirus [25,26].
Table 1. Overview of assumptions used in calculating DALYs averted, adapted from Table 7.6, Guidelines for Drinking-water Quality,
4
th Edition [24].
Units
Probability density function (pdf)
for independent variables
Values (independent variables) or formulae
(dependent variables)
Untreated water quality (CR) Mean organisms per litre Log-normal (mean=standard deviation) Means of 0.0001, , 0.001, 0.01, 0.1, or 1
Log10 reduction Unitless Uniform between bound specified 1–2, 2.01–3, or 3.01–6
Drinking-water quality (CD) Organisms per litre CR6(12% reduction)
Consumption of drinking-water (V) Litres per person per day Mean (point estimate) 1, 2, or 5
Adherence or consistency of
drinking water treatment (A)
Percent of water consumed
that is treated (%)
Uniform between bound specified 50–70%, 71–90%, or 91–100%
Exposure by drinking-water (D) Organisms per day ingested - Equation (1)
Risk of infection (Pinf,d) Per day - Equations (2, 3)
Risk of infection (Pinf,y) Per year - Equation (4)
Risk of diarrhoeal illness given
infection (Pill|inf)
Mean (point estimate) Campylobacter: 0.3, rotavirus: 0.5, Cryptosporidium:
0.7
Risk of diarrhoeal illness (Pill) Per year - Equation (5)
Disease burden (DB) DALYs per case Uniform between bound specified (for
rotavirus only)
Campylobacter: 4.6610
23, rotavirus: 0.014–0.48,
Cryptosporidium:1 . 5 610
23
Susceptible fraction (S) Percentage of population Mean (point estimate) Campylobacter: 100%, rotavirus: 6%,
Cryptosporidium: 100%
Disease burden per 100,000
persons
DALYs per year per 100,000 - Equation (6)
doi:10.1371/journal.pone.0036735.t001
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Pinf,y~1{ 1{Pinf,d
 365 ð4Þ
The risk of illness is calculated as:
Pill,y~Pinf,d|Pill inf j ð5Þ
where the probability of illness given infection (Pill|inf) is 0.3 for
Campylobacter, 0.5 for rotavirus, and 0.7 for Cryptosporidium [24].
To calculate the disease burden in DALYs associated with
yearly risk of illness, we used the following formula for each
reference microbe:
DALYs~Pill|DB|S ð6Þ
Where DB is the estimated per-case disease burden in DALYs and
S is the susceptible fraction of the population for the outcome of
interest. Per-case DALY weights are 4.6610
23 (campylobacter-
iosis), 0.014–0.48 (rotavirus), and 1.5610
23 (cryptosporidiosis).
The model further assumes that 100% of the population is
susceptible to cryptosporidiosis and campylobacteriosis, but that
only 6% is susceptible to illness associated with rotavirus infection
(Table 1). These DALYs weights and estimates for susceptible
fraction are those used in the base model as described in the WHO
Guidelines for Drinking-water Quality [25]. To calculate the estimated
disease burden among 100,000 person-years across all three
reference pathogens, we multiplied the microbe-specific disease
burden by 100,000 and summed estimates for Campylobacter,
Cryptosporidium, and rotavirus. Figures for averted DALYs were
then calculated as the difference between DALYs before and after
treatment, assuming that the only alternative to treated water was
untreated source water.
We conducted a four-way sensitivity analysis to determine the
relative sensitivity of mean DALYs averted to the key independent
variables of background water quality, litres consumed per day,
treatment effectiveness, and consistency/adherence. For the
sensitivity analysis, we used the single-hit model using means for
all inputs to examine variability in output resulting from changes
to independent variables of interest.
Results
Predicted health impacts associated with water quality inter-
ventions under pre-treatment water quality, technology effective-
ness, and adherence assumptions are presented in Table 2 as
DALYs averted per 100,000 people per year. For some
combinations of parameters resulting in high impact (moderate
pre-treatment water quality, medium to high treatment effective-
ness, and high adherence), point estimates for mean DALYs
averted per 100,000 person-years are over 500. With lower levels
of adherence, DALYs averted decrease dramatically when
untreated water is of high risk, since adherence is of greater
importance when untreated water is a source of disease. The range
of estimates of effect when pre-treatment water is of moderate to
high risk indicate that the potential health gains are very high as
adherence approaches 100% (up to 1840 DALYs per 100,000 per
year).
Results suggest that when pre-treatment water is of moderate to
high risk, adherence is more important than treatment effective-
ness. To take one example from Table 2, when pre-treatment
water is of moderate high risk, the mean estimated DALYs averted
per 100,000 person-years for a technology with low effectiveness
(1–2 log10 reduction of bacteria, viruses, and protozoa) but that is
used very consistently (91–100% adherence) is 363, compared with
68.1 for a technology that is more effective (3.01–6 log10 reduction
of bacteria, viruses, and protozoa) but that is used less consistently
(50–70% adherence).
Assuming lower risk untreated water, both the potential health
gains from water treatment and the sensitivity to adherence are
reduced, suggesting that the importance of water treatment and
high adherence are elevated in high-risk waters and reduced in
low-risk waters. We used a uniform probability density function in
the model to indicate ‘‘high’’ adherence between 91%–100%
(individual simulation estimates being equally likely to be assigned
a value between these in individual simulations), a range which
probably represents highest likely achievable adherence in situ.
Figure 1 presents a graphical illustration of how the predicted
health gains vary as a function of both adherence and pre-
treatment water quality. Calculation of DALYs averted in Figure 1
assumed a 2 log10 reduction across all reference pathogens and 1
litre per day consumption. When pre-treatment water was of high
risk [A] and [B], there is a dramatic decline in predicted health
gains with decreasing adherence. Water that is of moderate risk
[C] is less affected by reduced adherence, although sharp declines
are observed. Waters that are already low risk [D] and [E] do not
show a strong association between DALYs averted and adherence
because the risk of drinking untreated water is already low.
Results of the sensitivity analysis (Table 3) indicate that model
output is highly sensitive to pre-treatment water quality and
adherence, moderately sensitive over the range of assumptions to
treatment effectiveness against waterborne pathogens, and rela-
tively insensitive to volume consumed per person per day over
realistic values (1–5 litres per day per person). A straightforward
comparison of point estimates across changes in water quality,
adherence, effectiveness and consumption suggest that, within pre-
treatment water risk categories, DALYs averted estimates are most
sensitive to adherence. Reducing adherence from 100% to 90%
reduces the number of DALYs averted by over 90% under some
model assumptions and up to 96%, with sharper declines when
pre-treatment water quality is higher risk (Table 3 and Figure 1).
The model was also very sensitive to the per-case DALY disease
burden estimates (data not shown), which have been derived
elsewhere and are key assumptions included in the base model we
used [25,26] (Table 1).
Discussion
When and where water is an important source of pathogen
exposure, water quality interventions can reduce exposure to
pathogens and result in improved health. Our results suggest,
however, that the potential health gains are reduced sharply with
even occasional consumption of untreated drinking water.
Our results are consistent with the findings of a similar QMRA
analysis by Hunter et al. (2009) [6]. This study concluded that the
health benefits of improved quality drinking water (as delivered by
centralised treatment and distribution) were limited if even a small
percentage of overall water consumed was of lower quality, for
example during interruptions of service in piped water supply of
when the alternative drinking-water source was surface water.
Hunter et al. concluded as we have that the overall risk attributable
to drinking water is controlled by those periods of higher exposure
risk when no quality protection is in place, reducing overall
impacts of water quality improvements significantly if the
intervention is not present a high percentage of the time. We
Adherence and Water Quality Interventions
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treatment water quality; treatment effectiveness against bacteria, viruses, and protozoa; and adherence.
Pre-treatment water
quality (log-normal
distribution)
Treatment effectiveness:
bacteria, viruses, and
protozoa
Adherence, percentage of total
water consumed that is treated
Mean DALYs averted
per 100,000 persons
(standard deviation) Range
Mean standard
error
High risk: High High (91–100%) 196 (178) 3.54–1,570 1.78
reference (3.01–6 log10) Medium (71–90%) 50.4 (28.7) 0–523 0.29
pathogens Low (50–70%) 21.5 (16.8) 0–129 0.17
present, Medium High (91–100%) 173 (140) 0–1,740 1.40
mean: (2.01–3 log10) Medium (71–90%) 49.2 (28.2) 0–494 0.28
1 per litre Low (50–70%) 20.8 (16.7) 0–86.0 0.17
Low High (91–100%) 104 (62.0) 0–1,010 0.62
(1–2 log10) Medium (71–90%) 43.3 (26.1) 0–347 0.26
Low (50–70%) 19.4 (15.9) 0–85.8 0.16
Moderate High High (91–100%) 520 (326) 29.5–1,840 3.26
high risk: (3.01–6 log10) Medium (71–90%) 174 (149) 4.91–1,130 1.49
reference Low (50–70%) 68.1 (62.6) 3.95–659 0.63
pathogens Medium High (91–100%) 498 (316) 36.0–1,890 3.16
present, (2.01–3 log10) Medium (71–90%) 170 (146) 6.82 (1,110) 1.46
mean: Low (50–70%) 69.0 (63.5) 1.14–676) 0.63
0.1 per litre Low High (91–100%) 363 (257) 20.0–1,460 2.57
(1–2 log10) Medium (71–90%) 147 (127) 5.41–998) 1.27
Low (50–70%) 63.7 (57.6) 2.93–604 0.58
Moderate High High (91–100%) 533 (313) 26.9–1,630 3.13
risk: (3.01–6 log10) Medium (71–90%) 369 (213) 19.3–1,180 2.13
reference Low (50–70%) 216 (131) 6.56–682 1.31
pathogens Medium High (91–100%) 527 (304) 31.4–1,650 3.04
present, (2.01–3 log10) Medium (71–90%) 365 (211) 18.6–1,140 2.11
mean: Low (50–70%) 215 (129) 6.69–724 1.29
0.01 per litre Low High (91–100%) 483 (277) 24.5–1,520 2.77
(1–2 log10) Medium (71–90%) 338 (196) 17.9–1,140 1.96
Low (50–70%) 206 (124) 8.23–676 1.24
Moderate High High (91–100%) 133 (127) 2.15–1,100 1.27
low risk: (3.01–6 log10) Medium (71–90%) 109 (102) 3.14–966 1.02
reference Low (50–70%) 78.5 (71.3) 2.29–557 0.71
pathogens Medium High (91–100%) 133 (125) 3.49–1,180 1.25
present, (2.01–3 log10) Medium (71–90%) 109 (101) 2.80–865 1.01
mean: Low (50–70%) 79.3 (70.5) 2.20–615 0.71
0.001 per Low High (91–100%) 129 (121) 2.06–1,070 1.21
litre (1–2 log10) Medium (71–90%) 105 (98.6) 2.55–885 0.99
Low (50–70%) 74.9 (67.0) 1.82–511 0.67
Low risk: High High (91–100%) 18.3 (15.9) 0–231 0.18
reference (3.01–6 log10) Medium (71–90%) 15.5 (13.3) 0–231 0.15
pathogens Low (50–70%) 11.5 (9.92) 0–212 0.12
present, Medium High (91–100%) 19.3 (15.8) 0–546 0.19
mean: (2.01–3 log10) Medium (71–90%) 16.1 (13.3) 0–311 0.16
0.0001 per Low (50–70%) 11.9 (9.94) 0–221 0.12
litre Low High (91–100%) 18.5 (15.5) 0–319 0.18
(1–2 log10) Medium (71–90%) 15.2 (12.9) 0–377 0.15
Low (50–70%) 11.3 (9.60) 0–157 0.11
doi:10.1371/journal.pone.0036735.t002
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tions generally, including centralized water treatment.
There is reason to believe, however, that there is even greater
risk among the estimated 1.2 billion who report treating water in
the home. First, most of those that practice HWT reside in low-
income settings where the risk of highly contaminated water is
greatest. Second, unlike residents of higher-income settings who
may receive warning when their water treatment systems fail, these
individuals are unable to judge the quality of their drinking water
and must follow the practice daily. Third, those who consistently
treat their water at home are likely to be exposed to untreated
drinking water when they are away from the home—a
fundamental shortcoming of HWT compared to effective com-
munity-wide improvements in water quality.
Reconciling these results with the existing evidence base for
water quality interventions raises certain questions. Our findings
suggest that the dramatic protective effects against diarrhoeal
disease reported in recent systematic reviews of household water
treatment [14,15,16,17] and other water quality interventions
[33,34] would seem to be unlikely in the absence of high
adherence. Unfortunately, even studies that report on coverage
and overall use rarely report on the extent to which participants
consume untreated water. Nevertheless, our findings are consistent
with two recent studies of the same water filter among young
children in low-income settings. While investigators found no
protective effect from an intervention in which most participants
acknowledged regularly drinking untreated water [19], the
intervention was highly protective against diarrhoea when few
participants consumed untreated water (Rachel Peletz, personal
communication).
Another potential explanation is that the large protective effects
reported by open trials of water quality interventions are
exaggerated due to reporting bias [15,18]. Correct, consistent
use has been an ongoing challenge for HWT, and few studies
appear to reach the levels of uptake that our results suggest would
be necessary to achieve the reported effects on diarrhoea. In this
respect, our results lend support to the assertion that published
health impact estimates of water quality interventions may have
been overestimated. An analysis of reported DALYs averted by
HWT interventions and a comparison with this and other
modelling efforts may be a useful next step in contextualizing
the evidence base for water quality interventions.
Another possibility that may explain higher than expected
estimates of health effects from trials with low apparent adherence
is that water quality interventions may have been more likely to
have been used consistently when untreated water was perceived
to be of higher risk due to aesthetic or other indicators, and those
perceptions may have correlated with actual levels of pathogens
(i.e., that adherence is higher when it is more important, when
water is of higher risk). More research is needed on whether and
how HWT behaviours are driven by perceptions of water safety,
and whether and how perceptions of water safety are related to
actual water safety.
Our results may also help explain the diminished health impact
that has been observed from longer-term evaluations of HWT
interventions [14,16]. A number of studies of HWT have shown
reduced use of HWT interventions over time, raising questions
about the potential for sustained use [19,20,21,22,23,24]. Tech-
nologies with a high user burden, recurrent costs, or those that
involve substantial behaviour change may be especially challeng-
ing to achieve the continued high adherence that our results
indicate is necessary to sustain health impact [35]. Boiling has
overcome many of these same obstacles and become the leading
HWT method worldwide [36]. However, studies of the effective-
ness of boiling demonstrate the challenge of achieving consistently
safe drinking water even from this highly normative practice.
Comparing predicted health gains resulting from two levels of
microbiological treatment effectiveness (2 log10 and 6 log10
reduction of reference pathogens) suggests decreasing marginal
health gains with increasing efficiency (Table 3). A focus on
Figure 1. DALYs averted per 100,000 population, per year, based on assumptions about technology effectiveness (2 log10
reduction in each pathogen class), adherence, and background water quality assumptions from Table 2.
doi:10.1371/journal.pone.0036735.g001
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tions, for example from 99% to 99.9999%, may not result in
proportionately lower risk, especially if adherence will be less than
100%; the swamping effect of lower than 100% adherence
essentially makes the real differences between microbial reduction
efficiencies meaningless with respect to outcomes as predicted in
this modelling exercise. We acknowledge that the value of
requiring higher efficiencies for water treatment technologies is
due to the higher efficiencies that may be required under outbreak
scenarios, when untreated water may be of higher risk, or if there
are no alternatives to high risk source waters. Given the fact that
some technologies may be adopted more readily and used more
consistently than other technologies (even those that may be more
effective in reducing microbes), these results would seem to suggest
that a focus on promoting adherence may be more critical in
delivering health gains than focusing exclusively on increasing
microbiological effectiveness [31].
The health impact estimates we report here should be
interpreted in light of the uncertainty of the assumptions and
necessary simplifications used to produce them. Pre-treatment
water quality, for example, is likely to be highly variable in any
given setting. Dose-response models for reference pathogens have
been derived from few studies, mostly using data from healthy
adults in wealthier countries. As an approach to estimating health
risk, QMRA incorporates a number of assumptions whose values
and ranges are uncertain. Where possible, we have attempted to
use assumptions that would tend to result in conservative estimates
of health impacts, and realistic ranges of pre-treatment water
quality, adherence, treatment effectiveness in reducing microbes,
and other key variables. QMRA is a quickly evolving approach
and models like the one we have used will benefit from further
refinement of methods and assumptions.
The greatest risks of waterborne disease globally are from
microbial pathogens, although chemical contaminants are locally
significant risks to public health. This risk assessment does not
address the potential problem of anthropogenic or naturally
occurring radiological or chemical contaminants that may be
present in drinking-water, including but not limited to pesticides,
arsenic, fluoride, heavy metals, nitrate, excess salts, disinfection by-
products, pharmaceuticals, or others. Our study also omits
helminthic and other diseases that may be transmitted by drinking
water. Including these additional factors would require additional
data and different modelling approaches.
Current guidelines supporting HWT emphasize the need for
correct, consistent and sustained use [31] and our results
underscore the need to make high adherence an essential priority
in HWT design and program implementation. In order to
maximise health gains from interventions, it is necessary to
provide HWT solutions that people will use exclusively or nearly
so. This may require not only intensified behaviour change
interventions, but also process improvements in HWT products
and technologies that minimize the likelihood of non-adherence.
In order to monitor and evaluate these and other water quality
interventions, it is also important to develop and improve tools for
monitoring and to ensure that field studies report adherence.
Given the challenges of achieving this high level of adherence
through point-of-use water treatment, these results also confirm
the need to continue efforts to provide safe, reliable, piped-in water
to household taps in order to realize the full promise of health
gains from water quality interventions.
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